BE881209A - Composition pharmaceutique pour lutter contre le taux de croissance des tumeurs et methode d'utilisation de celle-ci - Google Patents

Composition pharmaceutique pour lutter contre le taux de croissance des tumeurs et methode d'utilisation de celle-ci

Info

Publication number
BE881209A
BE881209A BE0/199012A BE199012A BE881209A BE 881209 A BE881209 A BE 881209A BE 0/199012 A BE0/199012 A BE 0/199012A BE 199012 A BE199012 A BE 199012A BE 881209 A BE881209 A BE 881209A
Authority
BE
Belgium
Prior art keywords
pharmaceutical composition
same
tumor growth
growth rate
controlling tumor
Prior art date
Application number
BE0/199012A
Other languages
English (en)
Inventor
P Bey
M Jung
Original Assignee
Merrell Toraude & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Toraude & Co filed Critical Merrell Toraude & Co
Publication of BE881209A publication Critical patent/BE881209A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C07D211/76—Oxygen atoms attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
BE0/199012A 1977-07-11 1980-01-17 Composition pharmaceutique pour lutter contre le taux de croissance des tumeurs et methode d'utilisation de celle-ci BE881209A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81476577A 1977-07-11 1977-07-11
US2875879A 1979-04-10 1979-04-10
US2875779A 1979-04-10 1979-04-10

Publications (1)

Publication Number Publication Date
BE881209A true BE881209A (fr) 1980-05-16

Family

ID=27363337

Family Applications (3)

Application Number Title Priority Date Filing Date
BE189191A BE868882A (fr) 1977-07-11 1978-07-10 Derives halogenomethyles d'alpha-aminoacides, leur preparation et leurs utilisations therapeutiques
BE0/199011A BE881208A (fr) 1977-07-11 1980-01-17 Composition pharmaceutique pour le traitement de psoriasis et methode d'utilisation de celle-ci
BE0/199012A BE881209A (fr) 1977-07-11 1980-01-17 Composition pharmaceutique pour lutter contre le taux de croissance des tumeurs et methode d'utilisation de celle-ci

Family Applications Before (2)

Application Number Title Priority Date Filing Date
BE189191A BE868882A (fr) 1977-07-11 1978-07-10 Derives halogenomethyles d'alpha-aminoacides, leur preparation et leurs utilisations therapeutiques
BE0/199011A BE881208A (fr) 1977-07-11 1980-01-17 Composition pharmaceutique pour le traitement de psoriasis et methode d'utilisation de celle-ci

Country Status (9)

Country Link
JP (1) JPS5419913A (fr)
AU (1) AU522660B2 (fr)
BE (3) BE868882A (fr)
CA (1) CA1091661A (fr)
CH (1) CH642055A5 (fr)
DE (1) DE2828739A1 (fr)
FR (1) FR2430418A1 (fr)
GB (1) GB2001960B (fr)
NL (2) NL190662C (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0326766A1 (fr) * 1988-02-05 1989-08-09 Merrell Dow Pharmaceuticals Inc. Dérivés 5-substitués d'ornithine
EP0228034A3 (en) * 1985-12-19 1990-05-09 Merrell Dow Pharmaceuticals Inc. Arginine and agmatine derivatives for treating protozoal infections
US6103220A (en) * 1998-01-23 2000-08-15 Levine; Martin Lysine decarboxylase inhibitors for the prevention and treatment of periodontal disease
US6187296B1 (en) 1998-01-23 2001-02-13 The Board Of Regents Of The University Of Oklahoma Lysine decarboxylase inhibitors for the prevention and treatment of periodontal disease

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399151A (en) 1980-06-16 1983-08-16 Merrell Dow Pharmaceuticals Inc. Method of inhibiting the growth of protozoa
PH16634A (en) * 1980-06-16 1983-12-05 Merrell Dow Pharma Method of inhibiting the growth of protozoa
GB2083030B (en) * 1980-08-23 1984-03-07 Merrell Toraude & Co Fluorinated pentene diamine derivatives
JPS5791958A (en) * 1980-08-23 1982-06-08 Merrell Toraude & Co Fluorinated pentene diamine derivative
US4437873A (en) 1981-03-23 1984-03-20 Merrell Dow Pharmaceuticals Inc. Method of inhibiting algae
US4423073A (en) 1981-08-19 1983-12-27 Merrell Toraude Et Compagnie Fluorinated diaminopentene derivatives
US4446151A (en) * 1981-08-19 1984-05-01 Merrell Toraude Et Compagnie Decarboxylase-inhibiting fluorinated pentane diamine derivatives
US4435425A (en) 1982-04-09 1984-03-06 Merrell Toraude Et Compagnie Fluorinated diaminobutane derivatives
CA1319123C (fr) * 1988-08-31 1993-06-15 Andrew T. Au Methode de preparation de (-)-derives de substitution en 2 d'ornithines
US7015349B2 (en) * 2003-03-26 2006-03-21 The Gillette Company Reduction of hair growth
WO2021209563A1 (fr) 2020-04-16 2021-10-21 Som Innovation Biotech, S.A. Composés destinés à être utilisés dans le traitement d'infections virales par un coronavirus associé au syndrome respiratoire
CN120943886B (zh) * 2025-10-16 2026-01-30 浙江肽昇生物医药有限公司 一种三肽Fmoc-Pro-Pro-Pro-OH的合成方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2392958A1 (fr) * 1977-06-01 1978-12-29 Merck & Co Inc Nouveaux amino-acides fluores utiles comme medicament

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0228034A3 (en) * 1985-12-19 1990-05-09 Merrell Dow Pharmaceuticals Inc. Arginine and agmatine derivatives for treating protozoal infections
EP0326766A1 (fr) * 1988-02-05 1989-08-09 Merrell Dow Pharmaceuticals Inc. Dérivés 5-substitués d'ornithine
US6103220A (en) * 1998-01-23 2000-08-15 Levine; Martin Lysine decarboxylase inhibitors for the prevention and treatment of periodontal disease
US6187296B1 (en) 1998-01-23 2001-02-13 The Board Of Regents Of The University Of Oklahoma Lysine decarboxylase inhibitors for the prevention and treatment of periodontal disease

Also Published As

Publication number Publication date
NL7807453A (nl) 1979-01-15
GB2001960A (en) 1979-02-14
NL190662C (nl) 1994-06-16
CH642055A5 (de) 1984-03-30
JPH0122259B2 (fr) 1989-04-25
FR2430418B1 (fr) 1984-07-13
NL190662B (nl) 1994-01-17
GB2001960B (en) 1982-02-24
NL950027I2 (nl) 1997-06-02
NL950027I1 (nl) 1996-02-01
AU522660B2 (en) 1982-06-17
JPS5419913A (en) 1979-02-15
BE868882A (fr) 1978-11-03
BE881208A (fr) 1980-05-16
FR2430418A1 (fr) 1980-02-01
DE2828739A1 (de) 1979-02-01
CA1091661A (fr) 1980-12-16
AU3732778A (en) 1980-01-03

Similar Documents

Publication Publication Date Title
BE881209A (fr) Composition pharmaceutique pour lutter contre le taux de croissance des tumeurs et methode d'utilisation de celle-ci
GB2006181B (en) Growth of biological material
NZ195703A (en) Treatment and control of mastitis and compositions therefor
PH15877A (en) Novel n-heterocyclyl-4-piperidiamines,pharmaceutical composition containing same and method of use
PH18091A (en) Novel spiro-oxazolidindiones,pharmaceutical compositions containing same and method of use thereof
IL55429A0 (en) Thiadiaolyl cephalosporin analogs, processes for the preparation thereof,pharmaceutical or veterinary compositions containing the same and method of inhibiting the growth of bacteria therewith
DE3176062D1 (en) Process and apparatus for controlling cultivation of microorganisms
PT79485A (en) Process for preparing oxazolidines and of pharmaceutical compositions containing the same
BE881550A (fr) Melange de stereoisomeres de 2-(4-chlorophenyl)-isovalerate d'alpha-cyano-3-(4-halogenophenoxy)-benzyle, son procede de preparation et composition en contenant
DE3069698D1 (en) Process and apparatus for accelerating growth rate of salmonoids and other fish and the like
ZA79964B (en) 2,6-dialkoxybenzamides,intermediates,pharmaceutical compositions and methods for treatment of psychotic disorders
DE3173499D1 (en) Novel thioesters and process for the preparation of the same
GB2105992B (en) Pharmaceutical composition for treatment of cardio-vascular diseases
DE3366608D1 (en) Heterocyclic compounds, their preparation, compositions containing them and method of controlling unwanted plant growth
ZA83918B (en) Process and composition for controlled nourishing of agricultural plants
PT76951B (en) Process for the preparation of racemic or optically active eburnane-oxime derivatives and pharmaceutical compositions containing them
PH17057A (en) Kijanimicin and salts thereof,pharmaceutical compositions containing same and process of preparring same
BE865926A (fr) Compositions purifiees d'urokinase et procede pour leur obtention
PT68556A (fr) Procede pour regler l'accroissement des plantes contenant-des composes azotes policicliques
PT74849A (en) Process for preparing new substituted 3-(parasubstituted) phenoxy-1-alkylamino-propanol-2-s and of pharmaceutical compositions containing the same
RO85533A (fr) Composition pour le reglage la croissance des plantes
GB2085008B (en) 1,5-bis-(2,3-dihydro-1,4-benzodioxin-2-yl)-3-azapentane-1,5-diols process for their manufacture pharmaceutical preparations containing these compounds and their therapeutic application
ZA836932B (en) Heterocyclic compounds,their preparation,compositions containing them and method of controlling unwanted plant growth
JPS5751196A (en) Melt for growing single crystal of magnetoplumbite and single crystal growth of magnetoplumbite
GB1553662A (en) Sterilization of fermentation media

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: MERREL TORAUDE ET CIE

Effective date: 20000117